Go Pro

Aptiv (APTV) Financials

Aptiv logo
$47.94 +1.41 (+3.03%)
As of 09/4/2026 03:58 PM Eastern
Annual Income Statements for Aptiv

Annual Income Statements for Aptiv

This table shows Aptiv's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
1,450 1,257 1,355 1,067 990 1,769 527 531 2,909 1,787 165
Consolidated Net Income / (Loss)
1,535 1,326 1,428 1,107 1,009 1,822 609 590 2,966 1,810 181
Net Income / (Loss) Continuing Operations
852 868 1,063 1,107 1,009 1,822 609 590 2,966 1,810 181
Total Pre-Tax Income
997 1,000 1,255 1,334 1,126 1,954 910 990 1,337 2,151 919
Total Operating Income
1,235 1,539 1,416 1,473 1,276 2,118 1,189 1,263 1,559 1,842 1,184
Total Gross Profit
2,173 2,747 2,614 2,729 2,646 1,940 2,436 2,635 3,439 3,711 3,898
Total Revenue
10,864 12,274 12,884 14,435 14,357 13,066 15,618 17,489 20,051 19,713 20,398
Operating Revenue
10,864 12,274 12,884 14,435 14,357 13,066 15,618 17,489 20,051 19,713 20,398
Total Cost of Revenue
8,691 9,527 10,270 11,706 11,711 11,126 13,182 14,854 16,612 16,002 16,500
Operating Cost of Revenue
8,691 9,527 10,270 11,706 11,711 11,126 13,182 14,854 16,612 16,002 16,500
Total Operating Expenses
938 1,208 1,198 1,256 1,370 -178 1,247 1,372 1,880 1,869 2,714
Selling, General & Admin Expense
803 924 952 993 1,076 976 1,075 1,138 1,436 1,465 1,673
Amortization Expense
70 117 117 154 146 144 148 149 233 211 208
Impairment Charge
- - - - - - - - 0.00 0.00 648
Restructuring Charge
65 167 129 109 148 136 24 85 211 193 185
Total Other Income / (Expense), net
-238 -539 -161 -139 -150 -164 -279 -273 -222 309 -265
Interest Expense
124 155 140 141 164 164 150 219 285 337 361
Interest & Investment Income
- - - 0.00 0.00 - - - 0.00 605 46
Other Income / (Expense), net
-114 -384 -21 2.00 14 0.00 -129 -54 63 41 50
Income Tax Expense
161 167 223 250 132 49 101 121 -1,928 223 700
Other Gains / (Losses), net
16 35 31 23 15 -83 -200 -279 -299 -118 -38
Preferred Stock Dividends Declared
- - - 0.00 0.00 35 63 63 29 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
85 69 73 40 19 18 19 -4.00 28 23 16
Basic Earnings per Share
$5.08 $4.60 $5.07 $4.04 $3.85 $6.72 $1.95 $1.96 $10.50 $6.97 $0.75
Weighted Average Basic Shares Outstanding
285.20M 273.02M 267.16M 264.41M 256.81M 263.43M 270.46M 270.90M 276.92M 256.38M 220M
Diluted Earnings per Share
$5.06 $4.59 $5.06 $4.02 $3.85 $6.66 $1.94 $1.96 $10.39 $6.96 $0.75
Weighted Average Diluted Shares Outstanding
286.64M 273.70M 268.03M 265.22M 257.39M 270.70M 271.22M 271.18M 282.88M 256.66M 220.75M
Weighted Average Basic & Diluted Shares Outstanding
285.40M 273.30M 267.30M 264.10M 255.29M 270.03M 270.51M 270.95M 279.04M 229.45M 212.75M

Quarterly Income Statements for Aptiv

This table shows Aptiv's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
905 218 938 363 268 -11 260 -355 138 189 248
Consolidated Net Income / (Loss)
919 224 943 368 275 -11 397 -352 147 191 247
Net Income / (Loss) Continuing Operations
919 224 943 368 275 -11 133 -352 147 191 -50
Total Pre-Tax Income
311 369 1,028 407 347 355 294 -243 354 285 663
Total Operating Income
355 419 441 503 479 448 325 -175 425 378 367
Total Gross Profit
922 878 968 903 962 920 731 1,018 963 920 775
Total Revenue
4,919 4,901 5,051 4,854 4,907 4,825 3,199 5,212 5,153 5,086 3,274
Operating Revenue
4,919 4,901 5,051 4,854 4,907 4,825 3,199 5,212 5,153 5,086 3,274
Total Cost of Revenue
3,997 4,023 4,083 3,951 3,945 3,905 2,468 4,194 4,190 4,166 2,499
Operating Cost of Revenue
3,997 4,023 4,083 3,951 3,945 3,905 2,468 4,194 4,190 4,166 2,499
Total Operating Expenses
567 459 527 400 483 472 406 1,193 538 542 408
Selling, General & Admin Expense
381 366 405 331 363 384 327 433 450 427 332
Amortization Expense
56 54 52 53 52 51 52 52 52 53 52
Restructuring Charge
130 39 70 16 68 37 27 60 36 62 24
Total Other Income / (Expense), net
-44 -50 587 -96 -216 -93 -31 -68 -70 -93 -1.00
Interest Expense
71 65 64 101 107 93 92 90 87 89 62
Interest & Investment Income
- - 641 0.00 - 0.00 46 0.00 1.00 0.00 3.00
Other Income / (Expense), net
27 15 10 5.00 11 0.00 15 22 16 -4.00 58
Income Tax Expense
-680 76 51 32 64 356 16 103 196 81 52
Other Gains / (Losses), net
-72 -69 -34 -7.00 - -10 -14 -6.00 -11 -13 -17
Net Income / (Loss) Discontinued Operations
- - - - - - - - - - -50
Net Income / (Loss) Attributable to Noncontrolling Interest
14 6.00 5.00 5.00 7.00 0.00 4.00 3.00 9.00 2.00 -1.00
Basic Earnings per Share
$3.36 $0.79 $3.47 $1.48 $1.23 ($0.05) $1.80 ($1.63) $0.63 $0.89 $1.17
Weighted Average Basic Shares Outstanding
276.92M 275.19M 270.19M 245.48M 256.38M 230.16M 217.73M 217.41M 220M 212.91M 211.56M
Diluted Earnings per Share
$3.25 $0.79 $3.47 $1.48 $1.22 ($0.05) $1.80 ($1.63) $0.63 $0.88 $1.17
Weighted Average Diluted Shares Outstanding
282.88M 275.31M 270.43M 245.78M 256.66M 230.16M 218.11M 217.41M 220.75M 213.80M 212.10M
Weighted Average Basic & Diluted Shares Outstanding
279.04M 272.06M 265.76M 235.04M 229.45M 217.73M 217.76M 216.08M 212.75M 211.62M 207.63M

Annual Cash Flow Statements for Aptiv

This table details how cash moves in and out of Aptiv's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-325 259 758 -1,029 -139 2,424 286 -1,584 85 -66 280
Net Cash From Operating Activities
1,703 1,941 1,468 1,628 1,624 1,413 1,222 1,263 1,896 2,446 2,185
Net Cash From Continuing Operating Activities
1,140 1,494 1,106 1,640 1,624 1,413 1,222 1,269 1,896 2,446 2,185
Net Income / (Loss) Continuing Operations
852 868 1,063 1,107 1,009 1,822 609 590 2,966 1,810 181
Consolidated Net Income / (Loss)
1,535 1,326 1,428 1,107 1,009 1,822 609 590 2,966 1,810 181
Depreciation Expense
274 372 429 522 571 620 625 613 679 753 783
Amortization Expense
81 126 124 161 152 153 156 164 242 223 217
Non-Cash Adjustments To Reconcile Net Income
112 36 54 6.00 100 -1,285 375 449 516 -367 803
Changes in Operating Assets and Liabilities, net
-179 92 -564 -156 -208 103 -543 -547 -2,507 27 201
Net Cash From Investing Activities
-1,699 -578 -1,252 -2,048 -1,111 -626 -729 -5,182 -1,002 -507 -498
Net Cash From Continuing Investing Activities
-1,429 -412 -1,093 -2,048 -1,111 -626 -729 -5,182 -1,002 -507 -502
Purchase of Property, Plant & Equipment
-503 -657 -698 -846 -781 -584 -611 -844 -906 -830 -656
Acquisitions
-1,657 -18 -374 -1,213 -344 -51 -132 -4,352 -89 -121 -42
Purchase of Investments
0.00 -1.00 -28 -2.00 0.00 -1.00 -17 7.00 6.00 -750 4.00
Sale of Property, Plant & Equipment
- - - - 14 10 9.00 4.00 4.00 6.00 16
Divestitures
724 245 - - - - 0.00 0.00 -17 448 164
Sale and/or Maturity of Investments
7.00 19 7.00 13 0.00 0.00 22 3.00 0.00 740 12
Net Cash From Financing Activities
-284 -1,081 456 -555 -649 1,613 -191 2,359 -807 -1,965 -1,442
Net Cash From Continuing Financing Activities
-284 -1,081 458 -555 -649 1,613 -191 2,337 -807 -1,965 -1,442
Repayment of Debt
-760 -896 -15 -13 -599 -429 -1,509 -27 -332 -3,836 -1,013
Repurchase of Common Equity
-1,159 -634 -383 -499 -420 -57 0.00 0.00 -398 -4,104 -397
Payment of Dividends
-349 -359 -348 -263 -237 -98 -63 -72 -34 0.00 -6.00
Issuance of Debt
2,043 852 796 268 641 0.00 1,450 2,472 0.00 6,001 0.00
Other Financing Activities, net
-59 -44 408 -48 -34 -33 -69 -36 -43 -26 -26
Effect of Exchange Rate Changes
-45 -23 - - - 24 -16 -24 -2.00 - 35

Quarterly Cash Flow Statements for Aptiv

This table details how cash moves in and out of Aptiv's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
506 -168 -699 468 -355 520 -473 348 194 211 1,323
Net Cash From Operating Activities
746 624 244 643 499 1,060 273 510 584 818 -143
Net Cash From Continuing Operating Activities
746 624 244 643 499 1,062 273 510 584 818 -143
Net Income / (Loss) Continuing Operations
1,637 919 224 943 368 275 -11 397 -352 147 191
Consolidated Net Income / (Loss)
1,637 919 224 943 368 275 -11 397 -352 147 191
Depreciation Expense
167 190 176 196 188 193 191 197 197 198 197
Amortization Expense
61 58 56 54 58 60 53 56 54 54 55
Non-Cash Adjustments To Reconcile Net Income
131 182 73 -570 28 65 33 36 723 11 56
Changes in Operating Assets and Liabilities, net
-1,250 -725 -285 20 -143 469 7.00 -176 -38 408 -642
Net Cash From Investing Activities
-205 -207 -305 -524 -255 577 -203 -9.00 -133 -153 -221
Net Cash From Continuing Investing Activities
-205 -207 -305 -524 -255 577 -203 -9.00 -133 -157 -221
Purchase of Property, Plant & Equipment
-212 -203 -265 -226 -173 -166 -197 -149 -143 -167 -219
Acquisitions
- -5.00 -40 - -81 - -12 -30 - - 0.00
Purchase of Investments
7.00 - 0.00 -748 -2.00 - 5.00 - -1.00 - -2.00
Sale of Property, Plant & Equipment
- 1.00 0.00 - 1.00 3.00 1.00 1.00 - 14 0.00
Divestitures
- - - - - - 0.00 - - -4.00 0.00
Sale and/or Maturity of Investments
- - - - - - 0.00 - 11 - 0.00
Net Cash From Financing Activities
-20 -606 -626 362 -624 -1,077 -553 -179 -253 -457 1,692
Net Cash From Continuing Financing Activities
-20 -606 -626 362 -624 -1,074 -553 -179 -253 -457 1,692
Repayment of Debt
-20 -302 -6.00 -5.00 -2,153 -1,074 -534 -179 -147 -153 229
Repurchase of Common Equity
- -300 -600 -430 -3,074 - 0.00 - -96 -301 -76
Payment of Dividends
- -2.00 - - - - 0.00 - - - -4.00
Issuance of Debt
- - - - 4,605 - 0.00 - - - 1,577
Other Financing Activities, net
- -2.00 -20 -1.00 -2.00 - -19 - -4.00 -3.00 -34
Effect of Exchange Rate Changes
- - -12 - - -40 10 26 -4.00 3.00 -5.00

Annual Balance Sheets for Aptiv

This table presents Aptiv's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
11,973 12,292 12,169 12,480 13,459 17,522 18,007 21,884 24,427 23,458 23,413
Total Current Assets
5,121 5,419 5,641 4,777 5,319 7,465 8,436 7,784 8,247 7,826 8,745
Cash & Equivalents
535 737 1,596 567 412 2,821 3,139 1,531 1,640 1,573 1,575
Restricted Cash
1.00 1.00 1.00 1.00 16 32 - - 0.00 1.00 3.00
Accounts Receivable
2,750 2,130 2,440 2,487 2,569 2,812 2,784 3,433 3,546 3,261 1,910
Inventories, net
1,181 859 1,083 1,277 1,286 1,297 2,014 2,340 2,365 2,320 1,789
Other Current Assets
431 302 521 445 504 503 499 480 696 671 627
Other Current Nonoperating Assets
223 1,390 - 0.00 532 - - - - - 2,841
Plant, Property, & Equipment, net
3,377 2,325 2,804 3,179 3,309 3,301 3,294 3,495 3,785 3,698 2,872
Total Noncurrent Assets
3,475 4,548 3,724 4,524 4,831 6,756 6,277 10,605 12,395 11,934 11,796
Long-Term Investments
94 67 91 99 106 2,011 1,797 1,723 1,443 1,433 1,288
Goodwill
1,539 1,502 1,944 2,524 2,407 2,580 2,511 5,106 5,151 5,024 4,008
Intangible Assets
1,383 1,148 1,219 1,380 1,186 1,091 964 2,585 2,399 2,140 1,997
Other Noncurrent Operating Assets
459 280 470 521 1,132 1,074 1,005 1,191 3,402 3,337 2,147
Other Noncurrent Nonoperating Assets
- 1,551 - - - - - - - - 2,356
Total Liabilities & Shareholders' Equity
11,973 12,292 12,169 12,480 13,459 17,522 18,007 21,884 24,427 23,458 23,413
Total Liabilities
9,240 9,529 8,652 8,810 9,448 9,422 9,446 12,790 12,583 14,373 13,914
Total Current Liabilities
3,927 4,148 3,540 3,694 4,054 4,046 4,207 4,865 4,808 5,131 5,037
Short-Term Debt
52 10 17 306 393 90 8.00 31 9.00 509 23
Accounts Payable
2,541 1,820 2,227 2,334 2,463 2,571 2,953 3,150 3,151 2,870 1,623
Accrued Expenses
1,204 1,242 1,296 1,054 1,155 1,385 1,246 1,684 1,648 1,752 1,191
Other Current Nonoperating Liabilities
130 1,076 - 0.00 43 - - - - - 2,200
Total Noncurrent Liabilities
5,313 5,381 5,112 5,116 5,394 5,376 5,239 7,925 7,775 9,242 8,877
Long-Term Debt
3,956 3,953 4,132 4,038 3,971 4,011 4,059 6,460 6,204 7,843 7,467
Capital Lease Obligations
- - - 0.00 - 300 304 361 453 412 270
Noncurrent Employee Benefit Liabilities
854 439 454 445 483 525 440 354 417 374 212
Other Noncurrent Operating Liabilities
503 371 526 633 940 540 436 750 701 613 479
Other Noncurrent Nonoperating Liabilities
- 618 - - - - - - - - 449
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - 0.00 96 99 92 102
Total Equity & Noncontrolling Interests
2,733 2,763 3,517 3,670 4,011 8,100 8,561 8,998 11,745 8,993 9,397
Total Preferred & Common Equity
2,250 2,401 3,299 3,459 3,819 7,905 8,347 8,809 11,548 8,796 9,207
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,250 2,401 3,299 3,459 3,819 7,905 8,347 8,809 11,548 8,796 9,207
Common Stock
1,656 1,636 1,652 1,642 1,648 3,900 3,942 3,992 4,031 2,968 3,621
Retained Earnings
1,627 1,980 2,118 2,511 2,890 4,550 5,077 5,608 8,162 7,002 6,227
Accumulated Other Comprehensive Income / (Loss)
-1,033 -1,215 -471 -694 -719 -545 -672 -791 -645 -1,174 -641
Noncontrolling Interest
483 362 218 211 192 195 214 189 197 197 190

Quarterly Balance Sheets for Aptiv

This table presents Aptiv's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
23,711 24,427 23,644 24,751 24,766 23,458 23,102 23,942 23,497 25,203 17,996
Total Current Assets
8,490 8,247 7,691 8,829 8,688 7,826 7,738 8,373 8,760 10,720 6,003
Cash & Equivalents
1,808 1,640 941 1,409 1,054 1,573 1,100 1,448 1,640 3,173 761
Restricted Cash
- 0.00 - - - 1.00 1.00 1.00 3.00 4.00 4.00
Accounts Receivable
3,647 3,546 3,652 3,592 3,653 3,261 3,549 3,717 3,713 3,798 2,434
Inventories, net
2,432 2,365 2,371 2,370 2,550 2,320 2,429 2,475 2,597 2,746 2,038
Other Current Assets
603 696 727 710 640 671 659 732 807 999 766
Other Current Nonoperating Assets
- - - - - - - - - - 0.00
Plant, Property, & Equipment, net
3,579 3,785 3,764 3,731 3,797 3,698 3,675 3,754 3,720 3,685 2,756
Total Noncurrent Assets
11,642 12,395 12,189 12,191 12,281 11,934 11,689 11,815 11,017 10,798 9,237
Long-Term Investments
1,498 1,443 1,363 1,506 1,503 1,433 1,431 1,311 1,303 1,418 1,255
Goodwill
5,073 5,151 5,110 5,078 5,170 5,024 5,088 5,248 4,593 4,548 3,937
Intangible Assets
2,423 2,399 2,326 2,263 2,235 2,140 2,105 2,105 2,055 1,940 1,875
Other Noncurrent Operating Assets
2,648 3,402 3,390 3,344 3,373 3,337 3,065 3,151 3,066 2,892 2,170
Other Noncurrent Nonoperating Assets
- - - - - - - - - - 0.00
Total Liabilities & Shareholders' Equity
23,711 24,427 23,644 24,751 24,766 23,458 23,102 23,942 23,497 25,203 17,996
Total Liabilities
12,638 12,583 12,225 12,981 15,568 14,373 13,848 13,967 13,933 15,681 9,243
Total Current Liabilities
4,696 4,808 5,956 5,908 5,804 5,131 4,794 4,751 4,885 5,069 2,975
Short-Term Debt
43 9.00 1,487 1,475 1,257 509 241 32 17 102 23
Accounts Payable
3,056 3,151 2,893 2,915 2,989 2,870 2,890 3,039 3,130 3,204 1,910
Accrued Expenses
1,597 1,648 1,576 1,518 1,558 1,752 1,663 1,680 1,738 1,763 1,042
Other Current Nonoperating Liabilities
- - - - - - - - - - 0.00
Total Noncurrent Liabilities
7,942 7,775 6,269 7,073 9,764 9,242 9,054 9,216 9,048 10,612 6,268
Long-Term Debt
6,419 6,204 4,721 5,504 8,283 7,843 7,646 7,758 7,613 9,248 5,331
Capital Lease Obligations
419 453 442 437 421 412 422 422 404 394 241
Noncurrent Employee Benefit Liabilities
372 417 418 407 413 374 390 426 432 416 212
Other Noncurrent Operating Liabilities
732 701 688 725 647 613 596 610 599 554 484
Other Noncurrent Nonoperating Liabilities
- - - - - - - - - - 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
93 99 97 95 99 92 95 103 102 99 0.00
Total Equity & Noncontrolling Interests
10,980 11,745 11,322 11,675 9,099 8,993 9,159 9,872 9,462 9,423 8,753
Total Preferred & Common Equity
10,778 11,548 11,120 11,467 8,882 8,796 8,961 9,690 9,282 9,233 8,753
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
10,778 11,548 11,120 11,467 8,882 8,796 8,961 9,690 9,282 9,233 8,753
Common Stock
4,035 4,031 3,971 3,950 2,942 2,968 3,374 3,607 3,634 3,601 3,615
Retained Earnings
7,522 8,162 7,847 8,401 6,734 7,002 6,598 6,797 6,357 6,351 5,578
Accumulated Other Comprehensive Income / (Loss)
-779 -645 -698 -884 -794 -1,174 -1,011 -714 -709 -719 -440
Noncontrolling Interest
202 197 202 208 217 197 198 182 180 190 0.00

Annual Metrics And Ratios for Aptiv

This table displays calculated financial ratios and metrics derived from Aptiv's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-29.91% 12.98% 4.97% 12.04% -0.54% -8.99% 19.53% 11.98% 14.65% -1.69% 3.47%
EBITDA Growth
-35.80% 11.99% 17.85% 10.78% -6.72% 43.62% -36.32% 7.88% 28.05% 12.62% -21.86%
EBIT Growth
-35.94% 3.03% 20.78% 5.73% -12.54% 64.19% -49.95% 14.06% 34.16% 16.09% -34.47%
NOPAT Growth
-30.05% 23.80% -9.17% 2.80% -5.89% 83.31% -48.81% 4.88% 243.41% -56.63% -82.91%
Net Income Growth
6.60% -13.62% 7.69% -22.48% -8.85% 80.57% -66.58% -3.12% 402.71% -38.98% -90.00%
EPS Growth
6.60% -13.62% 10.24% -20.55% -4.23% 72.99% -70.87% 1.03% 430.10% -33.01% -89.22%
Operating Cash Flow Growth
-20.23% 13.98% -24.37% 10.90% -0.25% -12.99% -13.52% 3.36% 50.12% 29.01% -10.67%
Free Cash Flow Firm Growth
-158.37% 361.18% -105.32% -23.24% 751.80% 58.72% -60.78% -613.92% 129.89% 108.56% -57.15%
Invested Capital Growth
51.32% -22.33% 27.90% 22.90% 0.07% 3.88% 4.70% 58.73% 21.55% -3.79% -4.55%
Revenue Q/Q Growth
-25.97% 2.92% 37.50% 1.38% -0.28% 4.95% -0.50% 2.98% 1.41% -0.06% 1.22%
EBITDA Q/Q Growth
-35.77% 9.18% 50.19% -0.42% -2.19% 6.37% -15.67% 18.21% 0.16% 4.11% -2.19%
EBIT Q/Q Growth
-36.31% 12.35% 49.20% -3.72% -1.60% 7.24% -23.36% 33.15% -2.87% 6.08% -3.82%
NOPAT Q/Q Growth
-32.06% 39.67% -3.46% 5.63% -1.49% 4.84% -11.96% 18.24% 23.35% -22.89% -39.58%
Net Income Q/Q Growth
-8.74% 6.85% -1.99% -1.77% -34.69% 48.37% -31.19% 62.53% 28.23% -26.24% -41.42%
EPS Q/Q Growth
-8.74% 6.85% -2.32% -1.23% -35.51% 50.34% -30.47% 71.93% 29.71% -22.58% -44.03%
Operating Cash Flow Q/Q Growth
-9.46% -0.61% -14.80% 25.33% -3.22% 7.29% -9.62% 26.43% -14.01% 21.69% -9.97%
Free Cash Flow Firm Q/Q Growth
-223.93% 972.06% -120.80% -115.39% 72.66% -16.06% -3.80% -1,075.91% 134.26% 128.59% -41.07%
Invested Capital Q/Q Growth
14.09% -28.03% -14.95% 4.30% -2.47% 3.38% 1.70% 50.52% 5.32% -6.13% -3.32%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
20.00% 22.38% 20.29% 18.91% 18.43% 14.85% 15.60% 15.07% 17.15% 18.83% 19.11%
EBITDA Margin
13.59% 13.47% 15.12% 14.95% 14.02% 22.13% 11.79% 11.36% 12.68% 14.53% 10.95%
Operating Margin
11.37% 12.54% 10.99% 10.20% 8.89% 16.21% 7.61% 7.22% 7.78% 9.34% 5.80%
EBIT Margin
10.32% 9.41% 10.83% 10.22% 8.99% 16.21% 6.79% 6.91% 8.09% 9.55% 6.05%
Profit (Net Income) Margin
14.13% 10.80% 11.08% 7.67% 7.03% 13.94% 3.90% 3.37% 14.79% 9.18% 0.89%
Tax Burden Percent
153.96% 132.60% 113.78% 82.98% 89.61% 93.24% 66.92% 59.60% 221.84% 84.15% 19.70%
Interest Burden Percent
88.94% 86.58% 89.96% 90.44% 87.29% 92.26% 85.85% 81.89% 82.43% 114.23% 74.47%
Effective Tax Rate
16.15% 16.70% 17.77% 18.74% 11.72% 2.51% 11.10% 12.22% -144.20% 10.37% 76.17%
Return on Invested Capital (ROIC)
20.72% 23.98% 21.86% 17.97% 15.33% 27.55% 13.52% 10.72% 27.08% 10.91% 1.95%
ROIC Less NNEP Spread (ROIC-NNEP)
44.23% 25.67% 33.92% 15.03% 11.98% 10.67% 100.69% -23.48% 3.65% 14.31% 0.00%
Return on Net Nonoperating Assets (RNNOA)
32.71% 24.27% 23.62% 12.84% 10.95% 2.54% -6.21% -4.03% 1.25% 6.39% 0.00%
Return on Equity (ROE)
53.43% 48.25% 45.48% 30.81% 26.27% 30.09% 7.31% 6.68% 28.33% 17.30% 1.95%
Cash Return on Invested Capital (CROIC)
-20.12% 49.12% -2.62% -2.58% 15.26% 23.75% 8.93% -34.68% 7.63% 14.77% 6.61%
Operating Return on Assets (OROA)
9.88% 9.52% 11.41% 11.97% 9.95% 13.67% 5.97% 6.06% 7.00% 7.86% 5.27%
Return on Assets (ROA)
13.53% 10.93% 11.68% 8.98% 7.78% 11.76% 3.43% 2.96% 12.81% 7.56% 0.77%
Return on Common Equity (ROCE)
44.26% 40.83% 41.28% 28.97% 24.89% 29.13% 7.13% 6.49% 27.55% 16.81% 1.89%
Return on Equity Simple (ROE_SIMPLE)
68.22% 55.23% 43.29% 32.00% 26.42% 23.05% 7.30% 6.70% 25.68% 20.58% 0.00%
Net Operating Profit after Tax (NOPAT)
1,036 1,282 1,164 1,197 1,126 2,065 1,057 1,109 3,807 1,651 282
NOPAT Margin
9.53% 10.44% 9.04% 8.29% 7.85% 15.80% 6.77% 6.34% 18.99% 8.38% 1.38%
Net Nonoperating Expense Percent (NNEP)
-23.51% -1.69% -12.06% 2.93% 3.35% 16.88% -87.17% 34.20% 23.43% -3.40% 1.94%
Return On Investment Capital (ROIC_SIMPLE)
15.36% 19.06% 15.19% 14.94% 13.45% 16.52% 8.17% 6.99% 20.68% 9.30% 1.63%
Cost of Revenue to Revenue
80.00% 77.62% 79.71% 81.09% 81.57% 85.15% 84.40% 84.93% 82.85% 81.17% 80.89%
SG&A Expenses to Revenue
7.39% 7.53% 7.39% 6.88% 7.49% 7.47% 6.88% 6.51% 7.16% 7.43% 8.20%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
8.63% 9.84% 9.30% 8.70% 9.54% -1.36% 7.98% 7.84% 9.38% 9.48% 13.31%
Earnings before Interest and Taxes (EBIT)
1,121 1,155 1,395 1,475 1,290 2,118 1,060 1,209 1,622 1,883 1,234
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,476 1,653 1,948 2,158 2,013 2,891 1,841 1,986 2,543 2,864 2,234
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
10.11 7.33 8.36 4.63 6.33 4.45 5.35 2.86 2.20 1.62 1.79
Price to Tangible Book Value (P/TBV)
0.00 0.00 202.89 0.00 107.01 8.31 9.16 22.57 6.35 8.71 6.31
Price to Revenue (P/Rev)
2.09 1.43 2.14 1.11 1.68 2.69 2.86 1.44 1.27 0.72 0.81
Price to Earnings (P/E)
15.69 13.99 20.36 15.01 24.43 19.89 84.67 47.52 8.72 7.95 99.65
Dividend Yield
1.23% 1.79% 22.09% 29.69% 0.93% 0.68% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
6.38% 7.15% 4.91% 6.66% 4.09% 5.03% 1.18% 2.10% 11.46% 12.57% 1.00%
Enterprise Value to Invested Capital (EV/IC)
4.42 4.52 5.06 2.71 3.84 4.57 5.54 2.29 1.90 1.37 1.51
Enterprise Value to Revenue (EV/Rev)
2.45 1.72 2.35 1.38 1.96 2.67 2.83 1.66 1.46 1.03 1.05
Enterprise Value to EBITDA (EV/EBITDA)
18.03 12.77 15.54 9.22 14.01 12.08 24.05 14.66 11.51 7.07 9.58
Enterprise Value to EBIT (EV/EBIT)
23.73 18.28 21.70 13.49 21.86 16.48 41.76 24.08 18.04 10.76 17.34
Enterprise Value to NOPAT (EV/NOPAT)
25.69 16.47 26.00 16.62 25.04 16.91 41.88 26.26 7.68 12.27 75.85
Enterprise Value to Operating Cash Flow (EV/OCF)
15.62 10.88 20.62 12.22 17.37 24.71 36.23 23.05 15.43 8.28 9.79
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 8.04 0.00 0.00 25.15 19.62 63.42 0.00 27.29 9.06 22.34
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.47 1.43 1.18 1.18 1.09 0.54 0.51 0.75 0.56 0.96 0.84
Long-Term Debt to Equity
1.45 1.43 1.17 1.10 0.99 0.53 0.51 0.75 0.56 0.91 0.83
Financial Leverage
0.74 0.95 0.70 0.85 0.91 0.24 -0.06 0.17 0.34 0.45 0.56
Leverage Ratio
3.95 4.42 3.90 3.43 3.38 2.56 2.13 2.26 2.21 2.29 2.52
Compound Leverage Factor
3.51 3.82 3.50 3.10 2.95 2.36 1.83 1.85 1.82 2.61 1.88
Debt to Total Capital
59.46% 58.92% 54.12% 54.21% 52.11% 35.21% 33.80% 42.97% 36.01% 49.10% 45.57%
Short-Term Debt to Total Capital
0.77% 0.15% 0.22% 3.82% 4.69% 0.72% 0.06% 0.19% 0.05% 2.85% 0.46%
Long-Term Debt to Total Capital
58.69% 58.77% 53.90% 50.39% 47.41% 34.49% 33.74% 42.78% 35.96% 46.25% 45.10%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
7.17% 5.38% 2.84% 2.63% 2.29% 1.56% 1.65% 1.79% 1.60% 1.62% 1.67%
Common Equity to Total Capital
33.38% 35.70% 43.03% 43.16% 45.60% 63.23% 64.55% 55.24% 62.39% 49.28% 52.76%
Debt to EBITDA
2.72 2.40 2.13 2.01 2.17 1.52 2.37 3.45 2.62 3.06 3.56
Net Debt to EBITDA
2.29 1.91 1.26 1.70 1.90 -0.16 -0.31 1.81 1.41 2.01 2.09
Long-Term Debt to EBITDA
2.68 2.39 2.12 1.87 1.97 1.49 2.37 3.43 2.62 2.88 3.52
Debt to NOPAT
3.87 3.09 3.56 3.63 3.87 2.13 4.14 6.18 1.75 5.31 28.18
Net Debt to NOPAT
3.26 2.46 2.11 3.07 3.40 -0.22 -0.53 3.25 0.94 3.49 16.54
Long-Term Debt to NOPAT
3.82 3.08 3.55 3.37 3.53 2.09 4.13 6.15 1.75 5.00 27.90
Altman Z-Score
3.00 2.77 3.80 3.02 3.33 3.98 4.57 2.68 2.89 2.25 2.32
Noncontrolling Interest Sharing Ratio
17.16% 15.37% 9.24% 5.97% 5.25% 3.20% 2.45% 2.83% 2.77% 2.80% 3.13%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.30 1.31 1.59 1.29 1.31 1.85 2.01 1.60 1.72 1.53 1.74
Quick Ratio
0.84 0.69 1.14 0.83 0.74 1.39 1.41 1.02 1.08 0.94 1.06
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-1,005 2,626 -140 -172 1,121 1,780 698 -3,587 1,072 2,236 958
Operating Cash Flow to CapEx
338.57% 295.43% 210.32% 192.44% 211.73% 246.17% 202.99% 150.36% 210.20% 296.84% 341.41%
Free Cash Flow to Firm to Interest Expense
-8.11 16.94 -1.00 -1.22 6.84 10.85 4.65 -16.38 3.76 6.64 2.65
Operating Cash Flow to Interest Expense
13.73 12.52 10.49 11.55 9.90 8.62 8.15 5.77 6.65 7.26 6.05
Operating Cash Flow Less CapEx to Interest Expense
9.68 8.28 5.50 5.55 5.23 5.12 4.13 1.93 3.49 4.81 4.28
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.96 1.01 1.05 1.17 1.11 0.84 0.88 0.88 0.87 0.82 0.87
Accounts Receivable Turnover
4.22 5.03 5.64 5.86 5.68 4.86 5.58 5.63 5.75 5.79 6.05
Inventory Turnover
7.92 9.34 10.58 9.92 9.14 8.61 7.96 6.82 7.06 6.83 6.76
Fixed Asset Turnover
3.40 4.31 5.02 4.83 4.43 3.95 4.74 5.15 5.51 5.27 5.46
Accounts Payable Turnover
3.61 4.37 5.08 5.13 4.88 4.42 4.77 4.87 5.27 5.32 5.48
Days Sales Outstanding (DSO)
86.51 72.56 64.73 62.29 64.27 75.16 65.39 64.88 63.52 63.02 60.28
Days Inventory Outstanding (DIO)
46.07 39.08 34.51 36.79 39.94 42.37 45.84 53.49 51.69 53.43 53.99
Days Payable Outstanding (DPO)
101.19 83.54 71.92 71.11 74.75 82.57 76.48 74.98 69.22 68.67 66.66
Cash Conversion Cycle (CCC)
31.39 28.10 27.33 27.98 29.46 34.96 34.75 43.39 45.99 47.78 47.61
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
6,018 4,674 5,978 7,347 7,352 7,637 7,996 12,692 15,427 14,842 14,166
Invested Capital Turnover
2.17 2.30 2.42 2.17 1.95 1.74 2.00 1.69 1.43 1.30 1.41
Increase / (Decrease) in Invested Capital
2,041 -1,344 1,304 1,369 5.00 285 359 4,696 2,735 -585 -676
Enterprise Value (EV)
26,605 21,108 30,273 19,898 28,205 34,914 44,270 29,117 29,257 20,261 21,400
Market Capitalization
22,744 17,588 27,594 16,010 24,183 35,182 44,621 25,234 25,378 14,215 16,441
Book Value per Share
$8.03 $8.87 $12.41 $13.13 $14.96 $29.28 $30.86 $32.51 $40.83 $37.42 $42.61
Tangible Book Value per Share
($2.40) ($0.92) $0.51 ($1.69) $0.89 $15.68 $18.01 $4.13 $14.13 $6.94 $12.07
Total Capital
6,741 6,726 7,666 8,014 8,375 12,501 12,932 15,946 18,510 17,849 17,451
Total Debt
4,008 3,963 4,149 4,344 4,364 4,401 4,371 6,852 6,666 8,764 7,952
Total Long-Term Debt
3,956 3,953 4,132 4,038 3,971 4,311 4,363 6,821 6,657 8,255 7,871
Net Debt
3,378 3,158 2,461 3,677 3,830 -463 -565 3,598 3,583 5,757 4,667
Capital Expenditures (CapEx)
503 657 698 846 767 574 602 840 902 824 640
Debt-free, Cash-free Net Working Capital (DFCFNWC)
710 543 521 821 1,230 656 1,098 1,419 1,808 1,630 1,935
Debt-free Net Working Capital (DFNWC)
1,246 1,281 2,118 1,389 1,658 3,509 4,237 2,950 3,448 3,204 3,789
Net Working Capital (NWC)
1,194 1,271 2,101 1,083 1,265 3,419 4,229 2,919 3,439 2,695 3,708
Net Nonoperating Expense (NNE)
-499 -44 -264 90 117 243 448 519 841 -159 101
Net Nonoperating Obligations (NNO)
3,285 1,911 2,461 3,677 3,341 -463 -565 3,598 3,583 5,757 4,667
Total Depreciation and Amortization (D&A)
355 498 553 683 723 773 781 777 921 981 1,000
Debt-free, Cash-free Net Working Capital to Revenue
6.54% 4.42% 4.04% 5.69% 8.57% 5.02% 7.03% 8.11% 9.02% 8.27% 9.49%
Debt-free Net Working Capital to Revenue
11.47% 10.44% 16.44% 9.62% 11.55% 26.86% 27.13% 16.87% 17.20% 16.25% 18.58%
Net Working Capital to Revenue
10.99% 10.36% 16.31% 7.50% 8.81% 26.17% 27.08% 16.69% 17.15% 13.67% 18.18%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $3.85 $6.72 $1.95 $1.96 $10.50 $6.97 $0.75
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 0.00 256.81M 263.43M 270.46M 270.90M 276.92M 256.38M 220M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $3.85 $6.66 $1.94 $1.96 $10.39 $6.96 $0.75
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 0.00 257.39M 270.70M 271.22M 271.18M 282.88M 256.66M 220.75M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 255.29M 270.03M 270.51M 270.95M 279.04M 229.45M 212.75M
Normalized Net Operating Profit after Tax (NOPAT)
1,090 1,421 1,270 1,286 1,257 2,197 1,078 1,183 1,239 1,824 1,412
Normalized NOPAT Margin
10.03% 11.58% 9.86% 8.91% 8.76% 16.82% 6.90% 6.77% 6.18% 9.25% 6.92%
Pre Tax Income Margin
9.18% 8.15% 9.74% 9.24% 7.84% 14.95% 5.83% 5.66% 6.67% 10.91% 4.51%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
9.04 7.45 9.96 10.46 7.87 12.91 7.07 5.52 5.69 5.59 3.42
NOPAT to Interest Expense
8.35 8.27 8.32 8.49 6.87 12.59 7.05 5.06 13.36 4.90 0.78
EBIT Less CapEx to Interest Expense
4.98 3.21 4.98 4.46 3.19 9.41 3.05 1.68 2.53 3.14 1.65
NOPAT Less CapEx to Interest Expense
4.29 4.03 3.33 2.49 2.19 9.09 3.03 1.23 10.19 2.45 -0.99
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
22.74% 27.07% 24.37% 23.76% 23.49% 5.38% 10.34% 12.20% 1.15% 0.00% 3.31%
Augmented Payout Ratio
98.24% 74.89% 51.19% 68.83% 65.11% 8.51% 10.34% 12.20% 14.57% 226.74% 222.65%

Quarterly Metrics And Ratios for Aptiv

This table displays calculated financial ratios and metrics derived from Aptiv's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 212,748,401.00 211,620,527.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 212,748,401.00 211,620,527.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.89 1.17
Growth Metrics
- - - - - - - - - - -
Revenue Growth
6.01% 1.72% -2.87% -5.08% -0.24% -1.55% 3.11% 7.38% 5.01% 5.41% 2.34%
EBITDA Growth
0.64% 17.88% 8.18% 7.71% 17.94% 3.90% 7.13% -87.00% -6.10% -9.54% -0.63%
EBIT Growth
-11.16% 25.07% 7.13% 7.63% 28.27% 3.23% 10.42% -130.12% -10.00% -16.52% 25.00%
NOPAT Growth
175.83% 8.82% 11.84% -75.86% -65.47% -100.38% 4.44% -126.43% -51.44% 21,540.13% 10.06%
Net Income Growth
245.49% 36.59% 283.33% -77.52% -70.08% -104.91% -57.90% -195.65% -46.55% 1,836.36% -37.78%
EPS Growth
273.56% 46.30% 313.10% -74.31% -62.46% -106.33% -48.13% -210.14% -48.36% 1,860.00% -35.00%
Operating Cash Flow Growth
-33.12% 2,811.11% 20.19% -33.11% 69.87% 11.89% -20.68% 17.03% -22.83% -152.38% 0.00%
Free Cash Flow Firm Growth
62.58% 54.43% 65.98% 83.72% 160.83% 135.95% 133.93% 248.17% -11.27% -13.94% 752.25%
Invested Capital Growth
21.55% 17.70% 14.72% 7.94% -3.79% -4.66% -0.62% -7.33% -4.55% -2.40% -20.09%
Revenue Q/Q Growth
-3.81% -0.37% 3.06% -3.90% 1.09% -1.67% 7.94% 0.08% -1.13% -1.30% 0.00%
EBITDA Q/Q Growth
-10.00% 5.71% 5.26% 7.56% -1.46% -6.86% 8.53% -86.95% 607.14% -9.67% 0.00%
EBIT Q/Q Growth
-19.07% 13.61% 3.92% 12.64% -3.54% -8.57% 11.16% -130.72% 388.24% -15.19% 0.00%
NOPAT Q/Q Growth
-41.08% -70.59% 25.98% 10.58% -15.71% -100.32% 34,785.55% -127.99% 254.85% 42.64% 0.00%
Net Income Q/Q Growth
-43.86% -75.63% 320.98% -60.98% -25.27% -104.00% 3,709.09% -188.67% 141.76% 29.93% 0.00%
EPS Q/Q Growth
-43.58% -75.69% 339.24% -57.35% -17.57% -104.10% 3,700.00% -190.56% 138.65% 39.68% 0.00%
Operating Cash Flow Q/Q Growth
-16.35% -60.90% 163.52% -22.40% 112.42% -74.25% 86.81% 14.51% 40.07% -117.48% 0.00%
Free Cash Flow Firm Q/Q Growth
62.67% -27.09% 22.83% 55.52% 239.47% -24.90% -27.16% 94.20% -16.48% -27.16% 0.00%
Invested Capital Q/Q Growth
5.32% 2.19% -1.54% 1.86% -6.13% 1.27% 2.63% -5.02% -3.32% 3.56% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
18.74% 17.91% 19.16% 18.60% 19.60% 19.07% 19.14% 19.53% 18.69% 18.09% 23.67%
EBITDA Margin
12.81% 13.59% 13.88% 15.53% 15.14% 14.34% 14.42% 1.88% 13.45% 12.31% 14.57%
Operating Margin
7.22% 8.55% 8.73% 10.36% 9.76% 9.29% 9.33% -3.36% 8.25% 7.43% 11.21%
EBIT Margin
7.77% 8.86% 8.93% 10.47% 9.99% 9.29% 9.56% -2.94% 8.56% 7.35% 12.98%
Profit (Net Income) Margin
18.68% 4.57% 18.67% 7.58% 5.60% -0.23% 7.62% -6.75% 2.85% 3.76% 7.54%
Tax Burden Percent
295.50% 60.70% 91.73% 90.42% 79.25% -3.10% 87.64% 144.86% 41.53% 67.02% 37.25%
Interest Burden Percent
81.41% 85.02% 227.94% 80.12% 70.82% 79.24% 90.96% 158.82% 80.27% 76.20% 156.00%
Effective Tax Rate
-218.65% 20.60% 4.96% 7.86% 18.44% 100.28% 9.93% 0.00% 55.37% 28.42% 7.84%
Return on Invested Capital (ROIC)
32.80% 9.37% 11.42% 12.37% 10.37% -0.03% 10.75% -3.11% 5.18% 7.40% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
26.89% 6.81% 24.91% 10.49% 7.89% -0.23% 9.87% -7.03% 4.36% 5.94% 0.00%
Return on Net Nonoperating Assets (RNNOA)
9.22% 2.79% 9.08% 5.27% 3.52% -0.11% 4.18% -4.39% 2.44% 3.46% 0.00%
Return on Equity (ROE)
42.02% 12.16% 20.50% 17.64% 13.89% -0.14% 14.93% -7.50% 7.62% 10.86% 0.00%
Cash Return on Invested Capital (CROIC)
7.63% 9.70% 7.85% 6.42% 14.77% 14.06% 9.06% 10.68% 6.61% 6.17% 0.00%
Operating Return on Assets (OROA)
6.72% 7.86% 7.62% 8.52% 8.22% 7.80% 7.77% -2.45% 7.45% 6.29% 0.00%
Return on Assets (ROA)
16.18% 4.06% 15.93% 6.17% 4.61% -0.19% 6.20% -5.64% 2.48% 3.21% 0.00%
Return on Common Equity (ROCE)
40.85% 11.82% 19.93% 17.11% 13.50% -0.14% 14.52% -7.26% 7.38% 10.52% 0.00%
Return on Equity Simple (ROE_SIMPLE)
0.00% 27.21% 32.47% 27.63% 0.00% 17.58% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1,131 333 419 463 391 -1.26 438 -123 190 271 338
NOPAT Margin
23.00% 6.79% 8.30% 9.55% 7.96% -0.03% 8.40% -2.35% 3.68% 5.32% 10.33%
Net Nonoperating Expense Percent (NNEP)
5.91% 2.57% -13.50% 1.87% 2.48% 0.19% 0.88% 3.92% 0.82% 1.46% 2.02%
Return On Investment Capital (ROIC_SIMPLE)
6.14% 1.85% 2.20% 2.43% 2.20% -0.01% 2.42% -0.70% 1.09% 1.41% 2.36%
Cost of Revenue to Revenue
81.26% 82.09% 80.84% 81.40% 80.40% 80.93% 80.86% 80.47% 81.31% 81.91% 76.33%
SG&A Expenses to Revenue
7.75% 7.47% 8.02% 6.82% 7.40% 7.96% 7.80% 8.31% 8.73% 8.40% 10.14%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
11.53% 9.37% 10.43% 8.24% 9.84% 9.78% 9.81% 22.89% 10.44% 10.66% 12.46%
Earnings before Interest and Taxes (EBIT)
382 434 451 508 490 448 498 -153 441 374 425
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
630 666 701 754 743 692 751 98 693 626 477
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.20 0.00 1.67 2.15 1.62 1.52 1.53 2.02 1.79 1.38 1.48
Price to Tangible Book Value (P/TBV)
6.35 0.00 4.64 12.96 8.71 7.72 6.36 7.13 6.31 4.65 4.42
Price to Revenue (P/Rev)
1.27 0.00 0.96 0.97 0.72 0.70 0.75 0.93 0.81 0.62 0.00
Price to Earnings (P/E)
8.72 0.00 5.19 7.90 7.95 8.76 14.66 63.64 99.65 34.98 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 15.35%
Earnings Yield
11.46% 0.00% 19.26% 12.67% 12.57% 11.41% 6.82% 1.57% 1.00% 2.86% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.90 0.00 1.50 1.65 1.37 1.31 1.33 1.65 1.51 1.24 1.34
Enterprise Value to Revenue (EV/Rev)
1.46 0.00 1.16 1.32 1.03 1.00 1.04 1.20 1.05 0.88 0.00
Enterprise Value to EBITDA (EV/EBITDA)
11.51 0.00 8.61 9.48 7.07 6.82 7.00 10.57 9.58 8.40 0.00
Enterprise Value to EBIT (EV/EBIT)
18.04 0.00 13.35 14.69 10.76 10.40 10.59 18.82 17.34 15.70 0.00
Enterprise Value to NOPAT (EV/NOPAT)
7.68 0.00 7.41 12.17 12.27 13.79 15.76 51.71 75.85 32.73 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
15.43 0.00 10.29 12.97 8.28 7.97 8.79 9.95 9.79 10.29 12.26
Enterprise Value to Free Cash Flow (EV/FCFF)
27.29 0.00 20.35 26.65 9.06 9.11 14.68 14.85 22.34 19.87 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.56 0.58 0.63 1.08 0.96 0.90 0.82 0.84 0.84 1.02 0.64
Long-Term Debt to Equity
0.56 0.45 0.50 0.95 0.91 0.87 0.82 0.84 0.83 1.01 0.64
Financial Leverage
0.34 0.41 0.36 0.50 0.45 0.49 0.42 0.62 0.56 0.58 0.48
Leverage Ratio
2.21 2.19 2.20 2.39 2.29 2.26 2.24 2.57 2.52 2.57 2.24
Compound Leverage Factor
1.80 1.86 5.02 1.92 1.62 1.79 2.04 4.09 2.02 1.96 3.49
Debt to Total Capital
36.01% 36.80% 38.65% 51.99% 49.10% 47.31% 45.15% 45.65% 45.57% 50.58% 39.00%
Short-Term Debt to Total Capital
0.05% 8.23% 7.69% 6.56% 2.85% 1.37% 0.18% 0.10% 0.46% 0.53% 0.16%
Long-Term Debt to Total Capital
35.96% 28.57% 30.97% 45.43% 46.25% 45.94% 44.98% 45.56% 45.10% 50.05% 38.83%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.60% 1.65% 1.58% 1.65% 1.62% 1.67% 1.57% 1.60% 1.67% 1.50% 0.00%
Common Equity to Total Capital
62.39% 61.54% 59.77% 46.36% 49.28% 51.02% 53.28% 52.74% 52.76% 47.92% 61.01%
Debt to EBITDA
2.62 2.52 2.75 3.62 3.06 2.88 2.79 3.52 3.56 4.49 0.00
Net Debt to EBITDA
1.41 1.64 1.39 2.40 2.01 2.00 1.85 2.23 2.09 2.38 0.00
Long-Term Debt to EBITDA
2.62 1.95 2.20 3.16 2.88 2.79 2.78 3.51 3.52 4.45 0.00
Debt to NOPAT
1.75 1.76 2.37 4.65 5.31 5.81 6.29 17.20 28.18 17.51 0.00
Net Debt to NOPAT
0.94 1.15 1.20 3.09 3.49 4.04 4.17 10.90 16.54 9.26 0.00
Long-Term Debt to NOPAT
1.75 1.36 1.90 4.07 5.00 5.64 6.26 17.17 27.90 17.33 0.00
Altman Z-Score
2.72 0.00 2.37 2.12 2.06 2.06 2.11 2.22 2.20 1.98 0.00
Noncontrolling Interest Sharing Ratio
2.77% 2.84% 2.79% 3.01% 2.80% 2.86% 2.70% 3.19% 3.13% 3.10% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.72 1.29 1.49 1.50 1.53 1.61 1.76 1.79 1.74 2.11 2.02
Quick Ratio
1.08 0.77 0.97 0.95 0.94 0.97 1.09 1.10 1.06 1.38 1.07
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-1,604 -2,038 -1,573 -700 976 733 534 1,037 866 631 3,437
Operating Cash Flow to CapEx
308.91% 92.08% 284.51% 290.12% 650.31% 139.29% 344.59% 408.39% 534.64% -65.30% 0.00%
Free Cash Flow to Firm to Interest Expense
-22.59 -31.36 -24.58 -6.93 9.12 7.88 5.87 11.52 9.95 7.09 55.44
Operating Cash Flow to Interest Expense
8.79 3.75 10.05 4.94 9.91 2.94 5.60 6.49 9.40 -1.61 0.00
Operating Cash Flow Less CapEx to Interest Expense
5.94 -0.32 6.52 3.24 8.38 0.83 3.98 4.90 7.64 -4.07 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.87 0.89 0.85 0.81 0.82 0.84 0.81 0.84 0.87 0.86 0.00
Accounts Receivable Turnover
5.75 5.58 5.46 5.40 5.79 5.45 5.42 5.47 6.05 5.62 0.00
Inventory Turnover
7.06 6.83 6.87 6.44 6.83 6.62 6.61 6.32 6.76 6.48 0.00
Fixed Asset Turnover
5.51 5.51 5.46 5.35 5.27 5.28 5.29 5.36 5.46 5.61 0.00
Accounts Payable Turnover
5.27 5.63 5.49 5.31 5.32 5.49 5.38 5.31 5.48 5.50 0.00
Days Sales Outstanding (DSO)
63.52 65.41 66.85 67.54 63.02 66.92 67.39 66.71 60.28 64.90 0.00
Days Inventory Outstanding (DIO)
51.69 53.46 53.10 56.63 53.43 55.15 55.22 57.79 53.99 56.35 0.00
Days Payable Outstanding (DPO)
69.22 64.83 66.44 68.72 68.67 66.44 67.86 68.70 66.66 66.35 0.00
Cash Conversion Cycle (CCC)
45.99 54.04 53.52 55.46 47.78 55.63 54.75 55.79 47.61 54.90 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
15,427 15,765 15,523 15,811 14,842 15,031 15,427 14,652 14,166 14,671 12,328
Invested Capital Turnover
1.43 1.38 1.38 1.30 1.30 1.28 1.28 1.32 1.41 1.39 0.00
Increase / (Decrease) in Invested Capital
2,735 2,371 1,992 1,163 -585 -734 -96 -1,159 -676 -360 -3,099
Enterprise Value (EV)
29,257 0.00 23,215 26,066 20,261 19,722 20,591 24,145 21,400 18,206 16,564
Market Capitalization
25,378 0.00 19,159 19,137 14,215 13,652 14,854 18,775 16,441 12,768 12,989
Book Value per Share
$40.83 $40.41 $42.15 $33.42 $37.42 $39.05 $44.50 $42.62 $42.61 $43.40 $41.36
Tangible Book Value per Share
$14.13 $13.39 $15.17 $5.56 $6.94 $7.71 $10.73 $12.10 $12.07 $12.90 $13.90
Total Capital
18,510 18,069 19,186 19,159 17,849 17,563 18,187 17,598 17,451 19,266 14,348
Total Debt
6,666 6,650 7,416 9,961 8,764 8,309 8,212 8,034 7,952 9,744 5,595
Total Long-Term Debt
6,657 5,163 5,941 8,704 8,255 8,068 8,180 8,017 7,871 9,642 5,572
Net Debt
3,583 4,346 3,753 6,613 5,757 5,777 5,452 5,088 4,667 5,149 3,575
Capital Expenditures (CapEx)
202 265 226 172 163 196 148 143 153 219 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,808 2,281 2,239 2,296 1,630 2,084 2,205 2,249 1,935 2,576 2,286
Debt-free Net Working Capital (DFNWC)
3,448 3,222 4,396 4,141 3,204 3,185 3,654 3,892 3,789 5,753 3,051
Net Working Capital (NWC)
3,439 1,735 2,921 2,884 2,695 2,944 3,622 3,875 3,708 5,651 3,028
Net Nonoperating Expense (NNE)
212 109 -524 95 116 9.74 41 230 43 80 91
Net Nonoperating Obligations (NNO)
3,583 4,346 3,753 6,613 5,757 5,777 5,452 5,088 4,667 5,149 3,575
Total Depreciation and Amortization (D&A)
248 232 250 246 253 244 253 251 252 252 52
Debt-free, Cash-free Net Working Capital to Revenue
9.02% 11.33% 11.20% 11.64% 8.27% 10.61% 11.14% 11.16% 9.49% 12.47% 0.00%
Debt-free Net Working Capital to Revenue
17.20% 16.00% 22.00% 20.99% 16.25% 16.22% 18.46% 19.31% 18.58% 27.85% 0.00%
Net Working Capital to Revenue
17.15% 8.62% 14.62% 14.62% 13.67% 14.99% 18.30% 19.23% 18.18% 27.35% 0.00%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.36 $0.79 $3.47 $1.48 $1.23 ($0.05) $1.80 ($1.63) $0.63 $0.89 $1.17
Adjusted Weighted Average Basic Shares Outstanding
276.92M 275.19M 270.19M 245.48M 256.38M 230.16M 217.73M 217.41M 220M 212.91M 211.56M
Adjusted Diluted Earnings per Share
$3.25 $0.79 $3.47 $1.48 $1.22 ($0.05) $1.80 ($1.63) $0.63 $0.88 $1.17
Adjusted Weighted Average Diluted Shares Outstanding
282.88M 275.31M 270.43M 245.78M 256.66M 230.16M 218.11M 217.41M 220.75M 213.80M 212.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
279.04M 272.06M 265.76M 235.04M 229.45M 217.73M 217.76M 216.08M 212.75M 211.62M 207.63M
Normalized Net Operating Profit after Tax (NOPAT)
340 364 486 478 446 340 485 373 323 315 360
Normalized NOPAT Margin
6.90% 7.42% 9.61% 9.85% 9.09% 7.04% 9.30% 7.16% 6.26% 6.19% 11.01%
Pre Tax Income Margin
6.32% 7.53% 20.35% 8.38% 7.07% 7.36% 8.70% -4.66% 6.87% 5.60% 20.25%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
5.38 6.68 7.05 5.03 4.58 4.82 5.47 -1.70 5.07 4.20 6.85
NOPAT to Interest Expense
15.93 5.12 6.55 4.59 3.65 -0.01 4.81 -1.36 2.18 3.04 5.46
EBIT Less CapEx to Interest Expense
2.54 2.60 3.52 3.33 3.06 2.71 3.85 -3.29 3.31 1.74 0.00
NOPAT Less CapEx to Interest Expense
13.09 1.04 3.02 2.89 2.13 -2.12 3.18 -2.95 0.42 0.58 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
1.15% 0.59% 0.05% 0.08% 0.00% 0.00% 0.00% 1.94% 3.31% 2.61% 0.00%
Augmented Payout Ratio
14.57% 31.33% 35.78% 179.54% 226.74% 222.48% 298.74% 33.01% 222.65% 126.11% 0.00%

Financials Breakdown Chart

Key Financial Trends

Aptiv’s latest statements show improving operating profitability and a substantially lower debt burden, but weaker liquidity and inconsistent reported earnings data remain important risks for investors. Q2 2026 revenue was $3.27 billion, up approximately 2.3% from $3.20 billion in the restated Q2 2025 results. Gross profit increased to $775 million from $731 million, lifting the gross margin to roughly 23.7% from 22.9%. Operating income also improved to $367 million from $325 million.

The longer-term revenue trend is mixed. Quarterly revenue generally remained in the $4.6 billion-to-$5.2 billion range during 2022 through 2025, before falling to approximately $3.2 billion-$3.3 billion in the latest reported second quarters. This suggests that portfolio changes, divestitures, or reporting changes may be affecting comparability. Investors should focus on organic revenue growth and segment performance in future filings.

  • Operating margins improved: Q2 2026 operating income represented approximately 11.2% of revenue, compared with 10.2% in Q2 2025. Selling, general and administrative expense also declined to $332 million from $327 million only modestly despite higher revenue, while restructuring charges fell to $24 million from $27 million.
  • Debt reduction has been substantial: Total debt, including short-term debt, long-term debt and capital lease obligations, was approximately $5.60 billion at June 30, 2026, down from about $9.65 billion at June 30, 2025 and $8.87 billion at year-end 2024. Lower leverage should reduce financial risk and interest costs.
  • Interest expense is trending lower: Q2 2026 interest expense was $62 million, versus $92 million in Q2 2025, $90 million in Q3 2025 and $107 million in Q4 2024. This provides additional support for pretax profitability.
  • Operating cash flow remained positive: Aptiv generated $273 million, $510 million, $584 million and $818 million of operating cash flow in Q1 through Q4 2025, respectively. The improvement through the year indicates stronger cash conversion after the unusually weak first quarter.
  • Capital spending appears manageable: Quarterly capital expenditures generally ranged from approximately $143 million to $226 million in the available 2024-2025 data. Operating cash flow exceeded capital expenditures in Q2, Q3 and Q4 2025, producing positive operating cash flow after capital investment.
  • Share count has declined over the period: Diluted weighted-average shares fell from approximately 283 million in Q3 2023 to 212 million in Q2 2026. Continued share repurchases can support earnings per share when conducted at attractive valuations.
  • Liquidity is adequate but has weakened: Q2 2026 current assets of $6.00 billion exceeded current liabilities of $2.98 billion, implying a current ratio of roughly 2.0. However, cash and equivalents declined to $761 million from $1.45 billion in Q2 2025 and $1.57 billion at year-end 2024.
  • Asset composition requires monitoring: Goodwill and intangible assets totaled approximately $5.71 billion at June 30, 2026, or nearly one-third of total assets. These balances can be vulnerable to impairment charges if expected business performance deteriorates.
  • Reported earnings are difficult to reconcile: Q2 2026 shows consolidated net income of $247 million and net income attributable to common shareholders of $248 million, while continuing operations are reported at a $50 million loss and discontinued operations at another $50 million loss. Several earlier periods also contain restated figures that do not reconcile cleanly across income and cash-flow statements.
  • Profitability remains volatile: Aptiv reported a $355 million net loss attributable to common shareholders in Q3 2025, primarily reflecting a $648 million impairment charge and $60 million of restructuring costs. Although Q4 2025 and Q2 2026 returned to profitability, recurring restructuring charges and prior impairment activity highlight execution and portfolio risks.

Overall, Aptiv’s financial position has improved through debt repayment, lower interest expense and stronger operating cash flow. The primary questions for investors are whether the recent operating-margin improvement can continue, whether revenue can return to sustained growth, and how much of the latest earnings improvement reflects ongoing operations rather than reporting changes or nonrecurring items. Because the supplied statements include restatements and apparent classification inconsistencies, investors should verify the company’s latest filing before relying on headline net income or earnings-per-share figures.

09/05/26 06:27 AM ETAI Generated. May Contain Errors.

Aptiv Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Aptiv's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Over the last 10 years, Aptiv's net income changed from $1.54 billion in 2015 to $181 million in 2025, a change of -88.2%. See where experts think Aptiv is headed by visiting Aptiv's forecast page.

Aptiv's total operating income in 2025 was $1.18 billion, based on the following breakdown:
  • Total Gross Profit: $3.90 billion
  • Total Operating Expenses: $2.71 billion

Over the last 10 years, Aptiv's total revenue changed from $10.86 billion in 2015 to $20.40 billion in 2025, a change of 87.8%.

Aptiv's total liabilities were at $13.91 billion at the end of 2025, a 3.2% decrease from 2024, and a 50.6% increase since 2015.

In the past 10 years, Aptiv's cash and equivalents has ranged from $412 million in 2019 to $3.14 billion in 2021, and is currently $1.58 billion as of their latest financial filing in 2025.

Over the last 10 years, Aptiv's book value per share changed from 8.03 in 2015 to 42.61 in 2025, a change of 430.4%.



Financial statements for NYSE:APTV last updated on 9/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners